ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea

This study has been completed.

Sponsored by: Bispebjerg Hospital
Information provided by: Bispebjerg Hospital
ClinicalTrials.gov Identifier: NCT00483145
  Purpose

To evaluate efficacy and adverse effect from long-pulsed dye laser versus long-pulsed dye laser-mediated photodynamic therapy for acne vulgaris and rosacea.


Condition Intervention
Acne Vulgaris and Rosacea
Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate)
Device: Long-pulsed dye laser
Device: Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)

MedlinePlus related topics:   Acne    Rosacea   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Randomized, Single Blind, Active Control, Single Group Assignment
Official Title:   Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea

Further study details as provided by Bispebjerg Hospital:

Study Start Date:   November 2006
Study Completion Date:   November 2007

Arms Assigned Interventions
1: Active Comparator
Long-pulsed dye laser (Candela)
Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate) Device: Long-pulsed dye laser
2: Active Comparator
Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)
Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate) Device: Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both

Criteria

Inclusion Criteria:

  • Inflammatory acne and rosacea
  • Skin types I-IV

Exclusion Criteria:

  • Patients younger than 18 years
  • Skin types V and VI
  • Topical and systemic conventional acne treatments
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00483145

Locations
Denmark
Bispebjerg Hospital    
      Copenhagen NV, Denmark, 2400

Sponsors and Collaborators
Bispebjerg Hospital

Investigators
Principal Investigator:     Merete Hædersdal     Bispebjerg University Hospital    
  More Information

Responsible Party:   Bispebjerg Hospital ( Merete Hædersdal )
Study ID Numbers:   KF-01-328309
First Received:   June 4, 2007
Last Updated:   June 2, 2008
ClinicalTrials.gov Identifier:   NCT00483145
Health Authority:   Denmark: The Ministry of the Interior and Health

Study placed in the following topic categories:
Exanthema
Rosacea
Facial Dermatoses
Facies
Skin Diseases
Sebaceous Gland Diseases
Acne Vulgaris

Additional relevant MeSH terms:
Acneiform Eruptions

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers